{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:39:33Z","timestamp":1791221973585,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"National Institute of Allergy and Infectious Diseases of the National Institutes of Health","award":["R01AI101192"],"award-info":[{"award-number":["R01AI101192"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12985-015-0426-x","type":"journal-article","created":{"date-parts":[[2015,11,24]],"date-time":"2015-11-24T02:28:37Z","timestamp":1448332117000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Molecular interplay between T-Antigen and splicing factor, arginine\/serine-rich 1 (SRSF1) controls JC virus gene expression in glial cells"],"prefix":"10.1186","volume":"12","author":[{"given":"Michael","family":"Craigie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda-Lopez","family":"Otalora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilker Kudret","family":"Sariyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,11,24]]},"reference":[{"key":"426_CR1","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/1743-422X-10-264","volume":"23","author":"HS Wollebo","year":"2013","unstructured":"Wollebo HS, Woldemichaele B, Khalili K, Safak M, White MK. Epigenetic regulation of polyomavirus JC. Virol J. 2013;23:264\u201373.","journal-title":"Virol J"},{"key":"426_CR2","first-page":"495","volume":"12","author":"JR Berger","year":"2011","unstructured":"Berger JR, Khalili K. The pathogenesis of progressive multifocal leukoencephalopathy. Discov Med. 2011;12:495\u2013503.","journal-title":"Discov Med"},{"key":"426_CR3","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.ncl.2008.03.007","volume":"26","author":"T Weber","year":"2008","unstructured":"Weber T. Progressive multifocal leukoencephalopathy. Neurol Clin. 2008;26:833\u201354.","journal-title":"Neurol Clin"},{"key":"426_CR4","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1212\/WNL.41.11.1733","volume":"41","author":"RC Holman","year":"1991","unstructured":"Holman RC, Janssen RS, Buehler JW, Zelasky MT, Hooper WC. Epidemiology of progressive multifocal leukoencephalopathy in the United States: analysis of national mortality and AIDS surveillance data. Neurol. 1991;41:1733\u20136.","journal-title":"Neurol"},{"key":"426_CR5","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1086\/374358","volume":"36","author":"FJ San-Andres","year":"2003","unstructured":"San-Andres FJ, Rubio R, Castilla J, Pulido F, Palao G, de Pedro I, et al. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus. Clin Infect Dis. 2003;36:1177\u201385.","journal-title":"Clin Infect Dis"},{"key":"426_CR6","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJMoa043335","volume":"353","author":"WJ Sandborn","year":"2005","unstructured":"Sandborn WJ, Colombel JF, Enns R, Feagan BG, Hanauer SB. Natalizumab induction and maintenance therapy for Crohn\u2019s disease: International efficacy of Natalizumab as active Crohn\u2019s therapy, evaluation of natalizumab as continuous therapy trial group. N Engl J Med. 2005;353:1912\u201325.","journal-title":"N Engl J Med"},{"key":"426_CR7","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1056\/NEJMoa051847","volume":"353","author":"A Langer-Gould","year":"2005","unstructured":"Langer-Gould A, Atlas SW, Green AJ, Bollen AW, Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med. 2005;353:375\u201381.","journal-title":"N Engl J Med"},{"key":"426_CR8","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJMoa051782","volume":"353","author":"BK Kleinschimdt-DeMasters","year":"2005","unstructured":"Kleinschimdt-DeMasters BK, Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med. 2005;353:369\u201374.","journal-title":"N Engl J Med"},{"key":"426_CR9","doi-asserted-by":"crossref","unstructured":"Carson KR, Focosi D, Major EO, Petrini M, Richey EA, West DP, et al. Monoclonal antibody-associated progressive multifocal leukoencephalopathy in patients treated with rituximab, natalizumab, and efalizumab: A review from the research on adverse drug events and reports project. Lancet Oncol. 2009;10:816\u201324.","DOI":"10.1016\/S1470-2045(09)70161-5"},{"key":"426_CR10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0014630","volume":"6","author":"IK Sariyer","year":"2011","unstructured":"Sariyer IK, Khalili K. Regulation of human neurotropic JC virus replication by alternative splicing factor SF2\/ASF in glial cells. PLoS ONE. 2011;6, e14630.","journal-title":"PLoS ONE"},{"key":"426_CR11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.3109\/13550289509113966","volume":"1","author":"PW Trowbridge","year":"1995","unstructured":"Trowbridge PW, Frisque RJ. Identification of three new JC virus proteins generated by alternative splicing of the early viral mRNA. Neurovirol. 1995;1:195\u2013206.","journal-title":"Neurovirol"},{"key":"426_CR12","doi-asserted-by":"crossref","first-page":"10846","DOI":"10.1128\/JVI.00542-09","volume":"83","author":"MK White","year":"2009","unstructured":"White MK, Safak M, Khalili K. Regulation of gene expression in primate polyomaviruses. J Virol. 2009;83:10846\u201356.","journal-title":"J Virol"},{"key":"426_CR13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/1947601911424578","volume":"2","author":"E Uleri","year":"2011","unstructured":"Uleri E, Beltrami S, Gordon J, Dolei A, Sariyer IK. Extinction of tumor antigen expression by SF2\/ASF in JCV-transformed cells. Genes and Cancer. 2011;2:728\u201336.","journal-title":"Genes and Cancer"},{"key":"426_CR14","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/1743-422X-10-147","volume":"10","author":"E Uleri","year":"2013","unstructured":"Uleri E, Regan P, Dolei A, Sariyer IK. SF2\/ASF binding region within JC virus NCCR limits early gene transcription in glial cells. Virol J. 2013;10:147.","journal-title":"Virol J"},{"key":"426_CR15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.febslet.2010.02.041","volume":"584","author":"KS Duschene","year":"2010","unstructured":"Duschene KS, Broderick JB. The antiviral protein viperin is a radical SAM enzyme. FEBS Lett. 2010;584:1263.","journal-title":"FEBS Lett"},{"key":"426_CR16","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.bbrc.2009.12.070","volume":"391","author":"G Shaveta","year":"2010","unstructured":"Shaveta G, Shi J, Chow VT, Song J. Structural characterization reveals that viperin is a radical S-adenosyl-L-methionine (SAM) enzyme. Biochem Biophys Res Commun. 2010;391:1390.","journal-title":"Biochem Biophys Res Commun"},{"key":"426_CR17","doi-asserted-by":"crossref","first-page":"15125","DOI":"10.1073\/pnas.011593298","volume":"98","author":"KC Chin","year":"2001","unstructured":"Chin KC, Cresswell P. Viperin, an INF-inducible antiviral protein directly induced by human cytomegalovirus. Proc Natl Acad Sci U S A. 2001;98:15125.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"426_CR18","doi-asserted-by":"crossref","unstructured":"Seo JY, Yaneva R, Hinson ER, Cresswell P. Human cytomegalovirus directly induces the antiviral protein viperin to enhance infectivity. Science. 2011;332:1093\u20137.","DOI":"10.1126\/science.1202007"},{"key":"426_CR19","doi-asserted-by":"crossref","unstructured":"Goldmacher VS, Bartle LM, Skaletskaya A, Dionne CA, Kedersha NL, Vater CA, et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci U S A. 1999;96:12536.","DOI":"10.1073\/pnas.96.22.12536"},{"key":"426_CR20","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0300-9084(02)01367-6","volume":"84","author":"VS Goldmacher","year":"2002","unstructured":"Goldmacher VS. vMIA, a viral inhibitor of apoptosis targeting mitochondria. Biochimie. 2002;84:177.","journal-title":"Biochimie"},{"key":"426_CR21","doi-asserted-by":"crossref","unstructured":"Al-Barazi, H.O., Colberg-Poley, A.M. The human cytomegalovirus UL37 immediate-early regulatory protein is an integral membrane N-glycoprotein which traffics through the endoplasmic reticulum and Golgi apparatus. J Virol. 1996;70:7198\u20137208.","DOI":"10.1128\/JVI.70.10.7198-7208.1996"},{"key":"426_CR22","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1099\/0022-1317-81-7-1779","volume":"81","author":"AM Colberg-Poley","year":"2000","unstructured":"Colberg-Poley AM, Patel MB, Erezo DP, Slater JE. Human cytomegalovirus UL37 immediate-early regulatory proteins traffic through the secretory apparatus and to mitochondria. J Gen Virol. 2000;81:1779\u201389.","journal-title":"J Gen Virol"},{"key":"426_CR23","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2217\/fvl.10.12","volume":"5","author":"AS Saribas","year":"2010","unstructured":"Saribas AS, Ozdemir A, Lam C, Safak M. JC virus induced progressive multifocal leukoencephalopathy. Future Virol. 2010;5:313\u201323.","journal-title":"Future Virol"},{"key":"426_CR24","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/0042-6822(89)90381-4","volume":"170","author":"MS Lashgari","year":"1989","unstructured":"Lashgari MS, Tada H, Amini S, Khalili K. Regulation of JCVL promoter function: transactivation of JCVL promoter by JCV and SV40 early proteins. Virol. 1989;170:292\u20135.","journal-title":"Virol"},{"key":"426_CR25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/jcp.21326","volume":"215","author":"K Khalili","year":"2008","unstructured":"Khalili K, Sariyer IK, Safak M. Small tumor antigen of polyomaviruses: role in viral life cycle and cell transformation. J Cell Physiol. 2008;215:309\u201319.","journal-title":"J Cell Physiol"},{"key":"426_CR26","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1083\/jcb.138.2.225","volume":"118","author":"JF Caceres","year":"1997","unstructured":"Caceres JF, Misteli T, Screaton GR, Spector DL, Krainer AR. Role of the modular domains of SR proteins in subcellular localization and alternative splicing specificity. J Cell Biol. 1997;118:225\u201338.","journal-title":"J Cell Biol"},{"key":"426_CR27","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.virol.2014.07.054","volume":"468\u2013470","author":"O Otlu","year":"2014","unstructured":"Otlu O, De Simone F, Lopez-Otalora Y, Khalili K, Sariyer IK. The agnoprotein of Polyomavirus JC is Released by Infected Cells: Evidence for Its Cellular Uptake by Uninfected Neighboring Cells. Virology. 2014;468\u2013470:88\u201395.","journal-title":"Virology"},{"issue":"1\u20132","key":"426_CR28","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jneuroim.2010.11.013","volume":"233","author":"HS Wollebo","year":"2011","unstructured":"Wollebo HS, Safak M, Del Valle L, Khalili K, White MK. Role for tumor necrosis factor-\u03b1 in JC virus reactivation and progressive multifocal leukoencephalopathy. J Neuroimmunol. 2011;233(1\u20132):46\u201353.","journal-title":"J Neuroimmunol"}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-015-0426-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,11]],"date-time":"2020-09-11T19:23:17Z","timestamp":1599852197000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.virologyj.com\/content\/12\/1\/196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11,24]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["426"],"URL":"https:\/\/doi.org\/10.1186\/s12985-015-0426-x","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,24]]},"article-number":"196"}}